Commentary: Cashing in on the flu pandemic?
24 July 2009
Sita Shah
Please Login to read the full article.
24 July 2009
Sita Shah
sita.shah@informa.com
Pharmaceutical companies with flu treatments or vaccine manufacturing capacity undoubtedly stand to reap the benefits in their financial results as panic over swine flu spreads.
As the second-quarter and first-half results come in, companies such as Novartis, Roche and GlaxoSmithKline are...
Please Login to read the full article.
RELATED CONTENT
NEWS
- GSK to close three research units, open four more amid hopes for sales growth in 2012
- US Capitol Capsule: Obama jobs push may bode well for patent reform
- Gilenya and Tasigna drive new product growth at Novartis
- US Capitol Capsule: Will sequestration be a better outcome for biopharma?
COMMENT
Other Informa Comment
EVENTS
Today
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
